JUNEVITY Trademark

Trademark Overview


On Friday, August 4, 2023, a trademark application was filed for JUNEVITY with the United States Patent and Trademark Office. The USPTO has given the JUNEVITY trademark a serial number of 98117779. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 14, 2025. This trademark is owned by Junevity, Inc.. The JUNEVITY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of human diseases and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for the treatment of physiological diseases; pharmaceutical products for cell therapy to treat human diseases and disorders, as well as aging; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human aging, diseases, and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for gene therapy to treat human diseases and disorders; pharmaceutical gene therapy preparations to treat human diseases and disorders; chemical preparations for pharmace...

Research and development in the field of pharmaceutical development; medical and scientific research and development in connection with cell aging and restoration; research and development of new products in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of gene therapy, genome writing, and genome engineering; scientific research and development in the field of pharmaceutical preparations for gene therapy; scientific research and development in the field of enzyme preparations for gene and cell therapy; research and development services in the field of genomics; medical and scientific research in the fields of genomics; providing medical and scientific research information in the fields of genomics; medical and scientific research in the field of genetics for the purpose of elevating single cell genome variants in order to identify transcription factors; scientific research and development and scientific research consulting, all in t...
junevity

General Information


Serial Number98117779
Word MarkJUNEVITY
Filing DateFriday, August 4, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of human diseases and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for the treatment of physiological diseases; pharmaceutical products for cell therapy to treat human diseases and disorders, as well as aging; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human aging, diseases, and disorders, namely, metabolic disease, liver diseases, diabetes, obesity, muscle wasting and frailty, dementia and neurological diseases, skin diseases, chronic kidney disease, inflammatory diseases, and lung diseases; pharmaceutical preparations for gene therapy to treat human diseases and disorders; pharmaceutical gene therapy preparations to treat human diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for gene and cell therapy
Goods and ServicesResearch and development in the field of pharmaceutical development; medical and scientific research and development in connection with cell aging and restoration; research and development of new products in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of gene therapy, genome writing, and genome engineering; scientific research and development in the field of pharmaceutical preparations for gene therapy; scientific research and development in the field of enzyme preparations for gene and cell therapy; research and development services in the field of genomics; medical and scientific research in the fields of genomics; providing medical and scientific research information in the fields of genomics; medical and scientific research in the field of genetics for the purpose of elevating single cell genome variants in order to identify transcription factors; scientific research and development and scientific research consulting, all in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics in relation to disease treatment and aging; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the field of genomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for medical and scientific research in the field of genomics; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with detecting variants in cells to treat disease and mitigate aging; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics for the purpose of disease treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with aging

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, September 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJunevity, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94401

Party NameJunevity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94401

Trademark Events


Event DateEvent Description
Sunday, September 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 8, 2023NEW APPLICATION ENTERED
Wednesday, May 22, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 5, 2024ASSIGNED TO EXAMINER
Wednesday, May 22, 2024NON-FINAL ACTION E-MAILED
Tuesday, August 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT